Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Finnish listed company Fiskars Group in connection with acquisition
Mandate

Vinge has advised Finnish listed company Fiskars Group in connection with acquisition

September 15, 2023 M&A

Vinge has advised Finnish listed company Fiskars Group in connection with its acquisition of renowned Danish design company Georg Jensen for EUR 151.5 million from private equity firm Investcorp. Closing of the transaction is expected to take place in the beginning of Q4 2023, subject to customary closing conditions.

Georg Jensen is an iconic Danish design company, founded in 1904, and is globally recognized for its pioneering craftsmanship and timeless design in jewelry, watches, silverware, homeware and more. Fiskars, Finland's oldest company, is known for manufacturing kitchenware and garden products, Fiskars also has a number of design brands in its portfolio, including the Danish porcelain company Royal Copenhagen. The acquisition of Georg Jensen is intended to strengthen Fiskars' portfolio of luxury brands and support Fiskars' global growth strategy. Vinge advised Fiskars alongside Accura in connection with the transaction.

Vinge's team consisted mainly of Magnus Hedsund, Sofie Nordgren and Niklas Törnell.

 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026